Pay in 4 interest-free payments of $6.32 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Its very rare that you would even experience pinprick bleeding from the procedure
TB-500 Loading Phase Dose How long: 4 weeks for acute injuries, 6 weeks for chronic or post-surgical cases Dose: 2 to 2.5 mg subcutaneous, twice a week, on non-consecutive days (think Monday/Thursday or Tuesday/Friday) Weekly total: 4 to 5 mg Some people in the peptide community push higher, using 4 to 5 mg per injection, twice weekly (8 to 10 mg per week), for severe or long-standing injuries
If you are new to both, introduce them one at a time with at least four weeks between introductions so you can identify the source of any reaction
The peptide works through longer-term biological processes, not immediate effects
Description Drug Info: ApoThera Drug Disease Clinical Support App Storage Refrigerate at 2-8C (36-46F) If needed, each single-dose pen can be stored unrefrigerated at temperatures not to exceed 30C (86F) for up to 21 days Do not freeze Protect from light If needed, each single-dose pen can be stored unrefrigerated at temperatures not to exceed 30C (86F) for up to 21 days Do not freeze Protect from light Missed Dose 4 days Skip missed dose and administer next dose on regularly scheduled day In each case, patients can resume their regular once weekly dosing schedule How Zepbound Works SC Administration Administer SC in abdomen, thigh, or upper arm Rotate injection site with each dose Administer once weekly, at any time of day, with or without meals Change day of weekly administration: May be changed, if necessary, as long as time between the 2 doses is at least 3 days (72 hr) Rotate injection site with each dose Administer once weekly, at any time of day, with or without meals Change day of weekly administration: May be changed, if necessary, as long as time between the 2 doses is at least 3 days (72 hr) SC Preparation Inspect visually before use Solution should appear clear and colorless to slightly yellow
61 Buesing, S., Costa, M., Schilling, J
